Creating a uni ed, high-performing team is one of the most important factors for successful drug and device development in today’s changing global business environment.
It is essential that organisations recognise the importance of team interaction and
a need for the different individuals and teams to work together on productivity and quality as this vital element of team performance can often be overlooked.
This interactive workshop will focus on how to align members of a team and wider teams and functions, particularly working in a matrix or in a global environment. Through various group discussions, stimulating exercises and case studies, the workshop will help enhance teamwork and team performance.
Benefits of attending:
Learn how to build, lead and motivate your team to maximise results
Ensure effective communication between different team members
Discuss ways to ensure that your team understand their roles and what is expected of them to deliver successful results
Proactively identify issues and risks for the team and learn how to manage them effectively
Develop a high performing team which is aligned with the same vision
This course, designed speci cally for the pharmaceutical, device and animal health industries, will be relevant for existing team leaders, project managers and heads of department who wish to develop their team to perform at a higher level.
It will also be bene cial to any team member who wants to develop the skills to achieve greater success.
Developing your team leadership
Matrix team management
Team formation and development
Effective team communication
Motivating the team
Planning project team activities
Ensuring project team progress
Proactively identify issues and risks and learn how to manage them
Team problem-solving to ensure appropriate quality
Providing feedback to team members
Dr Laura Brown MBA, BSc,PhD, is a Pharmaceutical QA and Training Consultant, Course Director for the MSc in Clinical Research, School of Pharmacy at the University of Cardiff. She has more than 20 years’ experience of quality assurance in the pharmaceutical industry and has worked for several companies, including GSKs Hoechst Marion Roussel, Farmitalia and Phoenix International. She has a particular expertise in quality assurance including risked based approaches to quality systems, data Integrity and project management in the pharmaceutical industry. She regularly writes on pharmaceutical regulatory issues including “The Planning of International Drug Development”, in the Clinical Research Manual, Euromed and the “Impact of Brexit”, RQA Journal 2017.